Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rhabdomyosarcoma × trofosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrence 1 Medulloblastoma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 22 Vincristine 19 Irinotecan 18 Temozolomide 15 Filgrastim 13 Radiotherapy 12 Doxorubicin 12 Dactinomycin 12 Ifosfamide 11 Granulocyte Colony-Stimulating Factor 9 Etoposide 9 Melphalan 8 Magnetic Resonance Spectroscopy 8 pegfilgrastim 7 Vinorelbine 7 Sirolimus 7 Radiation 7 X-Rays 6 Topotecan 6 Specimen Handling 6 fludarabine 5 cixutumumab 5 Phantoms, Imaging 5 Gemcitabine 5 Busulfan 5 temsirolimus 4 fludarabine phosphate 4 etoposide phosphate 4 Thiotepa 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡